← All organizations
Highest phase reached
Phase 2
Timeline
2010s
- Jun 1, 2011
Aadi, LLC— Founded
2020s
- May 17, 2021
Aerpio Therapeutics— Acquired
- Nov 22, 2021
sirolimus— Marketing Organization
- Nov 22, 2021
sirolimus— NDA Secondary Org
Drugs by trial phase (16 distinct, 27 trials)
Phase 2 (8 own, 4 via acquisition)
Phase 1 (3 own, 1 via acquisition)
Indications
Studied for
- Carcinoma
- Chordoma
- Colorectal Neoplasms
- Drug Resistant Epilepsy
- Epilepsy
- Glioblastoma
- Glioma
- Hypertension
- Hypertension, Pulmonary
- Leigh Disease
- Lung Neoplasms
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Neuroendocrine Tumors
- Perivascular Epithelioid Cell Neoplasms
- Sarcoma
- Sarcoma, Ewing
- Syndrome
- Urinary Bladder Neoplasms
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (20)
- NCT03817515Lead sponsorN/A—
- NCT06494150CollaboratorPhase 2Oct 31, 2024
- NCT06308419CollaboratorPhase 1Aug 14, 2024
- NCT05997017Lead sponsorPhase 2Dec 31, 2023
- NCT05997017Study directorPhase 2Dec 31, 2023
- NCT05997056Lead sponsorPhase 2Dec 30, 2023
- NCT05997056Study directorPhase 2Dec 30, 2023
- NCT05840510CollaboratorPhase 1/Phase 2Aug 7, 2023
- NCT05661461Lead sponsorPhase 1Nov 23, 2022
- NCT05103358Lead sponsorPhase 2Dec 31, 2021
- NCT03747328Lead sponsorPhase 2Apr 1, 2019
- NCT03670030CollaboratorPhase 2Nov 1, 2018
- NCT03657420CollaboratorPhase 1Sep 30, 2018
- NCT03463265Lead sponsorPhase 2Aug 1, 2018
- NCT03646240CollaboratorPhase 1Jul 31, 2018
Details
- Founded
- Pacific Palisades, CA, US Jun 1, 2011
- Last known activity
- Oct 31, 2024